InsiderTrades

Form 4 for OGN Organon & Co.

Accepted 2022-05-05 00:00:00 ET · period of report 2022-05-04 · accession 0001104659-22-056635 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-05-05 2022-05-04 OGN WALSH MATTHEW M CFO F - Tax $32.44 -2,847 20.2K -12% -$92.4K
D 2022-05-05 2022-05-04 OGN WALSH MATTHEW M CFO M - OptEx — +8,310 23.0K +57% —
D 2022-05-05 2022-05-04 OGN WALSH MATTHEW M CFO M - OptEx $0.00 -8,310 8,310 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-04 F D 2,847 $32.44 20,153 D — —
2 Common Common Stock 2022-05-04 M A 8,310 — 23,000 D — — (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
3 Derivative Restricted Stock Units 2022-05-04 M D 8,310 $0.00 8,310 D — · 2022-05-04 to 2024-05-04 8,310 Common Stock (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. (F2) On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024.